Antinol® EAB-277® – The Executive Summary
Bone & JointCatDogEAB 277™EfficacySafety

Antinol® EAB-277® – The Executive Summary

www.antinolstudies.com/
Authors:
Vetz Petz Antinol

Vetz Petz Antinol

The Summary of the researches and publications on www.antinolstudies.com

 

 

 

Antinol® Rapid is a potent synergistic blend of 2 marine lipid extracts chosen for their unique enhancement formula called EAB-277®.

EAB-277® is the key active ingredient of this advanced formula formulated to promote optimal benefits through its synergistic efficacy contains > 90 free fatty acids full spectrum of Omega 3 including ETA, EPA, DHA as well as other key Polyunsaturated fatty acids (PUFAs) and antioxidants.

The two marine lipids used in Antinol® Rapid are proprietary and exclusively produced. The exact combination of 30mg lipid fractions from Perna canaliculus (New Zealand green lipped mussel) and 20mg high phospholipid krill oil is the result of years of research combining and isolating lipid groups and essential fatty acids to find the optimal nutrient synergy.

EAB-277®’s proprietary high phospholipid krill oil is high in polar lipid enrichment which enhances bioactivity “Potency” of this marine oil blend formula as a result of proven efficacy.

The Antinol® Rapid EAB-277® blend has been proven via laboratory tests to be more effective than either of the individual lipids alone in inhibiting inflammation markers such as nitric oxide, TNFα, and IL-6.

 

Antinol® Rapid Animal Clinical Studies:

 

  1. Evaluation of Green Lipped Mussel /Krill Oil (EAB-277), Biotaorientalis Extract, and an NSAID for Canine Hip Osteoarthritis Pain

  2. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524® and EAB-277®), and carprofen for the treatment of dogs with hip osteoarthritis

  3. A Randomized Placebo Controlled Trial – Preliminary Study of the effects of PCSO-524® and EAB-277 ® on Renal Protective Function in the case of long term NSAID use for osteoarthritis in dogs.

  4. The Effect of EAB-277® on Heart Rate Variability (HRV) in Dogs with Tracheal Collapse.

  5. Supplementary effect of EAB-277® in Combination with Prednisolone against Immune-Mediated Hemolytic Anemia in Dogs.

  6. Tracheal Collapse Study in Small Dogs.

  7. Effects of marine based fatty acid compound EAB-277® on coagulopathy in dogs.

  8. Safety Study of EAB-277® (Antinol® Plus) in Dogs.

  9. Safety Study of EAB-277® (Antinol® Plus) in Cats.

Read full text DOWNLOAD (EN) DOWNLOAD FOR PRINT Summary EAB-277® + PCSO-524®

Copy Citation

Antinol EAB-277® - Executive Summary www.antinolstudies.com/
COPY